Healthcare provider profile · identity verified

Casey Ryan Doggett, D.O.

Family Practice · SPOKANE, WA · NPI 1730412669

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	777	201
Lisinopril	Lisinopril	525	157
Levothyroxine Sodium	Levothyroxine Sodium	478	122
Omeprazole	Omeprazole	337	86
Metformin Hcl	Metformin Hcl	325	83
Amlodipine Besylate	Amlodipine Besylate	314	84
Losartan Potassium	Losartan Potassium	314	91
Rosuvastatin Calcium	Rosuvastatin Calcium	211	61
Tamsulosin Hcl	Tamsulosin Hcl	192	55
Simvastatin	Simvastatin	180	49
Hydrochlorothiazide	Hydrochlorothiazide	175	44
Metoprolol Succinate	Metoprolol Succinate	173	43
Albuterol Sulfate Hfa	Albuterol Sulfate	168	63
Gabapentin	Gabapentin	159	41
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	125	38
Pantoprazole Sodium	Pantoprazole Sodium	117	38
Potassium Chloride	Potassium Chloride	108	34
Sertraline Hcl	Sertraline Hcl	102	26
Furosemide	Furosemide	101	34
Trazodone Hcl	Trazodone Hcl	100	28
Jardiance	Empagliflozin	99	26
Metoprolol Tartrate	Metoprolol Tartrate	88	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	82	19
Allopurinol	Allopurinol	78	23
Clonazepam	Clonazepam	78	13
Metformin Hcl Er	Metformin Hcl	74	22
Chlorthalidone	Chlorthalidone	72	23
Fluoxetine Hcl	Fluoxetine Hcl	71	16
Fluticasone Propionate	Fluticasone Propionate	68	23
Citalopram Hbr	Citalopram Hydrobromide	67	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	67	20
Glipizide	Glipizide	61	14
Lorazepam	Lorazepam	60	16
Duloxetine Hcl	Duloxetine Hcl	58	14
Pravastatin Sodium	Pravastatin Sodium	54	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	50	15
Atenolol	Atenolol	46	suppressed
Clopidogrel	Clopidogrel Bisulfate	43	13
Paroxetine Hcl	Paroxetine Hcl	42	11
Tizanidine Hcl	Tizanidine Hcl	41	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	40	12
Eliquis	Apixaban	39	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	39	11
Xarelto	Rivaroxaban	39	suppressed
Carvedilol	Carvedilol	38	suppressed
Bupropion Hcl Sr	Bupropion Hcl	34	13
Clonidine Hcl	Clonidine Hcl	34	11
Nystatin	Nystatin	34	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	32	suppressed
Famotidine	Famotidine	32	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	32	12
Montelukast Sodium	Montelukast Sodium	32	11
Quetiapine Fumarate	Quetiapine Fumarate	32	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	30	suppressed
Lamotrigine	Lamotrigine	30	suppressed
Alendronate Sodium	Alendronate Sodium	29	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	29	suppressed
Eszopiclone	Eszopiclone	28	suppressed
Tramadol Hcl	Tramadol Hcl	28	12
Donepezil Hcl	Donepezil Hcl	27	suppressed
Oxycodone Hcl	Oxycodone Hcl	27	suppressed
Spironolactone	Spironolactone	27	suppressed
Bupropion Xl	Bupropion Hcl	26	suppressed
Buspirone Hcl	Buspirone Hcl	26	suppressed
Ondansetron Odt	Ondansetron	26	14
Lovastatin	Lovastatin	25	suppressed
Mirtazapine	Mirtazapine	25	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	25	suppressed
Synthroid	Levothyroxine Sodium	24	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	23	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Nifedipine Er	Nifedipine	23	suppressed
Trulicity	Dulaglutide	23	suppressed
Aripiprazole	Aripiprazole	22	suppressed
Lurasidone Hcl	Lurasidone Hcl	22	suppressed
Meloxicam	Meloxicam	22	suppressed
Methocarbamol	Methocarbamol	21	11
Triamcinolone Acetonide	Triamcinolone Acetonide	21	17
Arnuity Ellipta	Fluticasone Furoate	20	suppressed
Baclofen	Baclofen	20	suppressed
Finasteride	Finasteride	20	suppressed
Symbicort	Budesonide/Formoterol Fumarate	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Oxycontin	Oxycodone Hcl	19	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Glipizide Er	Glipizide	17	suppressed
Ozempic	Semaglutide	17	suppressed
Alprazolam	Alprazolam	16	suppressed
Glimepiride	Glimepiride	16	suppressed
Linzess	Linaclotide	16	suppressed
Pregabalin	Pregabalin	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Topiramate	Topiramate	16	suppressed
Varenicline Tartrate	Varenicline Tartrate	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Carbamazepine Er	Carbamazepine	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Temazepam	Temazepam	15	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Vraylar	Cariprazine Hcl	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Mupirocin	Mupirocin	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Ramipril	Ramipril	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Diazepam	Diazepam	12	suppressed
Estradiol	Estradiol	12	suppressed
Felodipine Er	Felodipine	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Carisoprodol	Carisoprodol	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error